Other OTC Pharmaceuticals - Benelux

Benelux

Highlights

In Benelux, the revenue generated in the market Other OTC Pharmaceuticals amounted to US$427.50m in 2024.
It is projected to experience an annual growth rate of 0.88% (CAGR 2024-2029).
When compared globally, the United States leads the pack with revenues reaching US$7.17bn in 2024.
In terms of per capita figures, each person in Benelux contributed US$14.23 in revenue in 2024.
In the Benelux region, there is a growing demand for natural and homeopathic OTC pharmaceuticals.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Benelux is experiencing steady growth due to several factors. Customer preferences for self-medication and convenience play a significant role in driving the demand for over-the-counter (OTC) pharmaceutical products. Additionally, local special circumstances and underlying macroeconomic factors contribute to the development of the market.

Customer preferences: Customers in Benelux have a strong preference for self-medication, which has fueled the growth of the Other OTC Pharmaceuticals market. Many individuals prefer to treat minor ailments and common health issues on their own, rather than visiting a healthcare professional. This preference is driven by factors such as convenience, cost-effectiveness, and the belief that self-medication can provide immediate relief. As a result, there is a high demand for OTC pharmaceutical products that are easily accessible and can be purchased without a prescription.

Trends in the market: One of the key trends in the Other OTC Pharmaceuticals market in Benelux is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are opting for natural alternatives. This trend is driven by a growing awareness of the potential side effects of synthetic drugs and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for OTC pharmaceutical products that are derived from natural sources and are perceived to be safer and more effective.Another trend in the market is the growing focus on preventive healthcare. Consumers are becoming proactive in managing their health and are seeking OTC pharmaceutical products that can help prevent illnesses and maintain overall well-being. This trend is driven by factors such as an aging population, increasing healthcare costs, and a desire for a healthier lifestyle. As a result, there is a rising demand for OTC pharmaceutical products that promote immune support, vitamins and supplements, and preventive treatments.

Local special circumstances: The Benelux region consists of three countries – Belgium, the Netherlands, and Luxembourg – each with its own unique healthcare system and regulations. While there are similarities in terms of customer preferences and market trends, there are also differences that impact the development of the Other OTC Pharmaceuticals market.For example, Belgium has a highly regulated healthcare system, with strict rules on the sale and advertising of pharmaceutical products. This can create challenges for OTC pharmaceutical companies in terms of marketing and distribution. On the other hand, the Netherlands has a more liberal approach to healthcare, allowing for easier access to OTC pharmaceutical products.

Underlying macroeconomic factors: The development of the Other OTC Pharmaceuticals market in Benelux is also influenced by underlying macroeconomic factors. Economic stability, disposable income levels, and healthcare expenditure all play a role in shaping the market.Benelux countries have a relatively high GDP per capita, which translates to higher disposable income levels. This enables consumers to spend more on healthcare products, including OTC pharmaceuticals. Additionally, the region has a well-developed healthcare infrastructure, with a high level of healthcare expenditure. This creates a favorable environment for the growth of the Other OTC Pharmaceuticals market.In conclusion, the Other OTC Pharmaceuticals market in Benelux is developing due to customer preferences for self-medication and convenience. The market is driven by trends such as the popularity of natural remedies and the focus on preventive healthcare. Local special circumstances, such as healthcare regulations, also impact the market. Furthermore, underlying macroeconomic factors, including economic stability and disposable income levels, contribute to the growth of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.